The Mood Disorders Program is actively seeking participants for the following studies. For more information about these studies, please call 215-503-2833
- Genetic testing study: Patients who have taken an antidepressant and EITHER:
a. Took the antidepressant and experienced significant side effects, OR
b. Took the antidepressant and did not have much improvement in the depression.
Genetic testing will be done by using a cotton swab rubbed inside the cheek. Participants will be provided the results and the study doctor will explain the results. There is no treatment in this study.
There will only be two study visits. Study visits and genetic testing will be provided at no cost. Participants will also be reimbursed for both their time and for travel.
- Sexual dysfunction study: Patients whose major depressive disorder has improved a lot with an antidepressant but who developed sexual dysfunction of any kind since starting the antidepressant. The aim of the study is to see if a newer antidepressant, vilazodone (Viibryd), has fewer side effects than sertraline (Zoloft).
Participants will receive one of two antidepressants: vilazodone (Viibryd) or sertraline (Zoloft). No patient will receive only placebo. The study will last for up to 11 weeks. Participants will receive study visits and medication at no cost. Participants will also be reimbursed for both their time and for travel.
- Excessive Sweating study: Patients with clinical depression who have complaints of excessive sweating thought to be a side effect of their antidepressant. Participants will have another medication added to an antidepressant to see if it reduces the sweating. All patients will receive the medication. No placebo is used.
For more information about any of these studies, please call (215) 503-2833
Depression Treatment Non-medication Study
A unique 8-week research study at Thomas Jefferson University and the Myrna Brind Center of Intergrative Medicine is evaluating a nutritional supplement that may help relieve depression symptoms. Enrolled participants will receive an initial evaluation, study nutritional supplement, and follow-up visits at no cost. For more information call
In the News
Matthew Wintersteen, Ph.D., Assistant Professor in the Department of Psychiatry and Human Behavior is the Principal Investigator of a $1.2 million subcontract for suicide prevention efforts from the Commonwealth of Pennsylvania received by Jefferson.
"Two of our faculty members will be among the awardees at the Philadelphia Psychiatric Society's Annual Benjamin Rush Awards Gala that will be held on Friday Friday, November 6, 2015 at the Merion Cricket Club in Haverford, PA. Fayez El-Gabalawi, MD will receive the Psychiatric Educator of the Year award, and Shivkumar Hatti, MD, will receive the Daniel Blain Award."